Liquid biopsy for infectious diseases: a focus on microbial cell-free DNA sequencing
Жидкостная биопсия при инфекционных заболеваниях: акцент на секвенировании внеклеточной ДНК микроорганизмов
2020-01-01
SCID: 54.1/cebu8x6j
Discuss with AI
infectious disease diagnosisliquid biopsymetagenomic next-generation sequencingmicrobial cell-free DNA sequencingpathogen detection
Figures from the paper
Abstract (AI)
Metagenomic next-generation sequencing (mNGS) of microbial cell-free DNA (mcfDNA sequencing) is becoming an attractive diagnostic modality for infectious diseases, allowing broad-range pathogen detection, noninvasive sampling, and rapid diagnosis. At this key juncture in the translation of metagenomics into clinical practice, an integrative perspective is needed to understand the significance of emerging mcfDNA sequencing technology. In this review, we summarized the actual performance of the mcfDNA sequencing tests recently used in health care settings for the diagnosis of a variety of infectious diseases and further focused on the practice considerations (challenges and solutions) for improving the accuracy and clinical relevance of the results produced by this evolving technique. Such knowledge will be helpful for physicians, microbiologists and researchers to understand what is going on in this quickly progressing field of non-invasive pathogen diagnosis by mcfDNA sequencing and promote the routine implementation of this technique in the diagnosis of infectious disease.
Key Findings
1
Clinical translation requires addressing challenges that affect test accuracy and the clinical relevance of generated results.
2
Improving interpretation and implementation practices could support routine use of microbial cell-free DNA sequencing for noninvasive pathogen diagnosis.
3
Microbial cell-free DNA metagenomic sequencing enables broad-range pathogen detection through noninvasive sampling and may accelerate infectious-disease diagnosis.
4
The review summarizes the real-world diagnostic performance of recently implemented microbial cell-free DNA sequencing tests across diverse infectious diseases.
Research Object
microbial cell-free DNA sequencing tests used for diagnosing infectious diseases
Research Subject
diagnostic performance, clinical relevance, and practice considerations for improving the accuracy of microbial cell-free DNA sequencing
Publication Details
Publication Date
2020-01-01
Journal
Publisher
ISSN
Cited by
171
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest